Novel therapies for multiple myeloma.
作者信息
Wallington-Beddoe Craig T, Pitson Stuart M
机构信息
Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
School of Medicine, The Flinders University of South Australia, Adelaide, Australia.
出版信息
Aging (Albany NY). 2017 Aug 28;9(8):1857-1858. doi: 10.18632/aging.101284.
Abstract
摘要
相似文献
1
Novel therapies for multiple myeloma.多发性骨髓瘤的新型疗法。
Aging (Albany NY). 2017 Aug 28;9(8):1857-1858. doi: 10.18632/aging.101284.
2
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?多发性骨髓瘤的单克隆抗体疗法：我们目前的状况与未来走向？
Immunotherapy. 2016;8(3):367-84. doi: 10.2217/imt.15.118. Epub 2016 Feb 17.
3
New Drugs in Multiple Myeloma.多发性骨髓瘤的新药。
Annu Rev Med. 2019 Jan 27;70:521-547. doi: 10.1146/annurev-med-112017-091045.
4
[Not Available].[无可用内容]
Praxis (Bern 1994). 2016;105(21):1255-1260. doi: 10.1024/1661-8157/a002493.
5
Post-transplant consolidation based on combination of lenalidomide and proteasome inhibitors in multiple myeloma.基于来那度胺和蛋白酶体抑制剂联合的移植后巩固治疗多发性骨髓瘤。
Panminerva Med. 2021 Mar;63(1):13-20. doi: 10.23736/S0031-0808.20.04141-5. Epub 2020 Sep 21.
6
Resistance to proteasome inhibitors and other targeted therapies in myeloma.多发性骨髓瘤中蛋白酶体抑制剂和其他靶向治疗的耐药性。
Br J Haematol. 2018 Jul;182(1):11-28. doi: 10.1111/bjh.15210. Epub 2018 Apr 20.
7
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials.达雷妥尤单抗单药治疗经大量预处理的复发或难治性多发性骨髓瘤患者：2期GEN501和SIRIUS试验的最终结果
Lancet Haematol. 2020 Jun;7(6):e447-e455. doi: 10.1016/S2352-3026(20)30081-8.
8
Age and aging in blood disorders: multiple myeloma.血液疾病中的年龄与衰老：多发性骨髓瘤
Haematologica. 2014 Jul;99(7):1133-7. doi: 10.3324/haematol.2014.110296.
9
Management of double-refractory multiple myeloma.双难治性多发性骨髓瘤的治疗管理。
Curr Hematol Malig Rep. 2013 Dec;8(4):253-60. doi: 10.1007/s11899-013-0173-2.
10
Emerging therapies in multiple myeloma.多发性骨髓瘤的新兴疗法
Am J Clin Oncol. 2015 Jun;38(3):315-21. doi: 10.1097/COC.0b013e3182a4676b.
引用本文的文献
1
Search for multiple myeloma risk factors using Mendelian randomization.使用孟德尔随机化方法寻找多发性骨髓瘤的危险因素。
Blood Adv. 2020 May 26;4(10):2172-2179. doi: 10.1182/bloodadvances.2020001502.
2
Heme oxygenase-1 inhibition mediates Gas6 to enhance bortezomib-sensitivity in multiple myeloma via ERK/STAT3 axis.血红素加氧酶-1 抑制介导 Gas6 通过 ERK/STAT3 轴增强硼替佐米在多发性骨髓瘤中的敏感性。
Aging (Albany NY). 2020 Apr 16;12(8):6611-6629. doi: 10.18632/aging.102996.
3
Autologous hematopoietic stem-cell transplant in small-sized and peripheral centers: a 10-year experiment.小型及周边中心的自体造血干细胞移植：一项为期10年的试验。
Ther Adv Hematol. 2019 Oct 5;10:2040620719879587. doi: 10.1177/2040620719879587. eCollection 2019.
本文引用的文献
1
Safety of ixazomib for the treatment of multiple myeloma.伊沙佐米治疗多发性骨髓瘤的安全性。
Expert Opin Drug Saf. 2017 Aug;16(8):973-980. doi: 10.1080/14740338.2017.1344212. Epub 2017 Jul 12.
2
Systematic review and meta-analysis of the efficacy and safety of novel monoclonal antibodies for treatment of relapsed/refractory multiple myeloma.新型单克隆抗体治疗复发/难治性多发性骨髓瘤疗效与安全性的系统评价和荟萃分析
Oncotarget. 2017 May 16;8(20):34001-34017. doi: 10.18632/oncotarget.16987.
3
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience.多发性骨髓瘤中的免疫调节药物：作用机制与临床经验
Drugs. 2017 Apr;77(5):505-520. doi: 10.1007/s40265-017-0689-1.
4
Multiple myeloma.多发性骨髓瘤。
Lancet. 2015 May 30;385(9983):2197-208. doi: 10.1016/S0140-6736(14)60493-1. Epub 2014 Dec 23.
5
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.多发性骨髓瘤患者的生存率持续提高：老年患者早期死亡率和结局的变化。
Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25.
6
Once- versus twice-weekly bortezomib induction therapy with CyBorD in newly diagnosed multiple myeloma.在新诊断的多发性骨髓瘤中，硼替佐米与环磷酰胺、硼替佐米和地塞米松（CyBorD）联合使用时，每周一次与每周两次诱导治疗的对比
Blood. 2010 Apr 22;115(16):3416-7. doi: 10.1182/blood-2010-02-271676.
7
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.蛋白酶体抑制剂在多发性骨髓瘤细胞中诱导终末未折叠蛋白反应。
Blood. 2006 Jun 15;107(12):4907-16. doi: 10.1182/blood-2005-08-3531. Epub 2006 Feb 28.
Zotero 插件